Professor Mark Blaskovich
Professor

Mark Blaskovich

Email: 
Phone: 
+61 7 334 62039
Mobile: 
0414955380

Background

Professor Mark Blaskovich is an antibiotic hunter and Director of Translation at the Institute for Molecular Bioscience at The University of Queensland. He is co-founder and former Director of the Centre for Superbug Solutions at IMB.

A medicinal chemist with 15 years of industrial drug development experience prior to his academic career, Mark has been developing new antibiotics to treat drug resistant pathogens and using modified antibiotics to detect bacterial infections. He is a co-founder of the Community for Open Antimicrobial Drug Discovery, a global antibiotic discovery initiative, and has led a number of UQ-industry collaborations focused on antibiotic development. An inventor on eleven patent families, Mark has developed drugs in clinical trials, published more than eighty research articles, and received over $10m in grant funding.

Availability

Professor Mark Blaskovich is:
Available for supervision
Media expert

Fields of research

Medicinal and biomolecular chemistry

Qualifications

  • Bachelor (Honours) of Science (Advanced), University of Victoria
  • Doctor of Philosophy, University of Waterloo

Search Professor Mark Blaskovich’s works on UQ eSpace

217 works between 1988 and 2025
All (217) Journal Article (170) Book Chapter (4) Conference Publication (12) Book (1) Other Outputs (30)

61 - 80 of 217 works

2022

Journal Article

Antimicrobial activity enhancers: towards smart delivery of antimicrobial agents

Skwarczynski, Mariusz, Bashiri, Sahra, Yuan, Ye, Ziora, Zyta M., Nabil, Osama, Masuda, Keita, Khongkow, Mattaka, Rimsueb, Natchanon, Cabral, Horacio, Ruktanonchai, Uracha, Blaskovich, Mark A. T. and Toth, Istvan (2022). Antimicrobial activity enhancers: towards smart delivery of antimicrobial agents. Antibiotics, 11 (3) 412, 412. doi: 10.3390/antibiotics11030412

Antimicrobial activity enhancers: towards smart delivery of antimicrobial agents

2022

Journal Article

Booster for antibiotics

Blaskovich, Mark (2022). Booster for antibiotics. Chemistry and Industry, 86 (3), 30-33. doi: 10.1002/cind.863_9.x

Booster for antibiotics

2022

Journal Article

Featured article editorial: discovery of a tricyclic β-lactam active against carbapenem-resistant enterobacterales

Blaskovich, Mark (2022). Featured article editorial: discovery of a tricyclic β-lactam active against carbapenem-resistant enterobacterales. ACS Infectious Diseases, 8 (3) acsinfecdis.2c00088, 398-398. doi: 10.1021/acsinfecdis.2c00088

Featured article editorial: discovery of a tricyclic β-lactam active against carbapenem-resistant enterobacterales

2022

Journal Article

Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection

De Oliveira, David M. P., Forde, Brian M., Phan, Minh-Duy, Steiner, Bernhard, Zhang, Bing, Zuegg, Johannes, El-deeb, Ibrahim M., Li, Gen, Keller, Nadia, Brouwer, Stephan, Harbison-Price, Nichaela, Cork, Amanda J., Bauer, Michelle J., Alquethamy, Saleh F., Beatson, Scott A., Roberts, Jason A., Paterson, David L., McEwan, Alastair G., Blaskovich, Mark A. T., Schembri, Mark A., McDevitt, Christopher A., von Itzstein, Mark and Walker, Mark J. (2022). Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection. mBio, 13 (1) e03517, e0351721. doi: 10.1128/mbio.03517-21

Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection

2022

Book Chapter

Application of antibiotic-derived fluorescent probes to bacterial studies

Zhang, Bing, Stone, M. Rhia L., Kc, Sanjaya, Łapińska, Urszula, Pagliara, Stefano and Blaskovich, Mark A.T. (2022). Application of antibiotic-derived fluorescent probes to bacterial studies. Methods in enzymology. (pp. 1-28) edited by Erin E. Carlson. San Diego, CA United States: Academic Press. doi: 10.1016/bs.mie.2021.11.010

Application of antibiotic-derived fluorescent probes to bacterial studies

2021

Journal Article

Loss of YhcB results in dysregulation of coordinated peptidoglycan, LPS and phospholipid synthesis during Escherichia coli cell growth

Goodall, Emily C. A., Isom, Georgia L., Rooke, Jessica L., Pullela, Karthik, Icke, Christopher, Yang, Zihao, Boelter, Gabriela, Jones, Alun, Warner, Isabel, Da Costa, Rochelle, Zhang, Bing, Rae, James, Tan, Wee Boon, Winkle, Matthias, Delhaye, Antoine, Heinz, Eva, Collet, Jean-Francois, Cunningham, Adam F., Blaskovich, Mark A., Parton, Robert G., Cole, Jeff A., Banzhaf, Manuel, Chng, Shu-Sin, Vollmer, Waldemar, Bryant, Jack A. and Henderson, Ian R. (2021). Loss of YhcB results in dysregulation of coordinated peptidoglycan, LPS and phospholipid synthesis during Escherichia coli cell growth. PLoS Genetics, 17 (12) e1009586, 1-40. doi: 10.1371/journal.pgen.1009586

Loss of YhcB results in dysregulation of coordinated peptidoglycan, LPS and phospholipid synthesis during Escherichia coli cell growth

2021

Journal Article

Biostimulation of bacteria in liquid culture for identification of new antimicrobial compounds

Mirzaee, Hooman, Ariens, Emily, Blaskovich, Mark A. T., Clark, Richard J. and Schenk, Peer M. (2021). Biostimulation of bacteria in liquid culture for identification of new antimicrobial compounds. Pharmaceuticals, 14 (12) 1232, 1232. doi: 10.3390/ph14121232

Biostimulation of bacteria in liquid culture for identification of new antimicrobial compounds

2021

Journal Article

CryoEM structure of the outer membrane secretin channel pIV from the f1 filamentous bacteriophage

Conners, Rebecca, McLaren, Mathew, Łapińska, Urszula, Sanders, Kelly, Stone, M. Rhia L., Blaskovich, Mark A. T., Pagliara, Stefano, Daum, Bertram, Rakonjac, Jasna and Gold, Vicki A. M. (2021). CryoEM structure of the outer membrane secretin channel pIV from the f1 filamentous bacteriophage. Nature Communications, 12 (1) 6316, 6316. doi: 10.1038/s41467-021-26610-3

CryoEM structure of the outer membrane secretin channel pIV from the f1 filamentous bacteriophage

2021

Journal Article

Instructive analysis of engineered carbon materials for potential application in water and wastewater treatment

Jain, Marut, Khan, Sadaf Aiman, Pandey, Ashish, Pant, Kamal Kishore, Ziora, Zyta Maria and Blaskovich, Mark A.T. (2021). Instructive analysis of engineered carbon materials for potential application in water and wastewater treatment. Science of The Total Environment, 793 148583, 1-19. doi: 10.1016/j.scitotenv.2021.148583

Instructive analysis of engineered carbon materials for potential application in water and wastewater treatment

2021

Journal Article

Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold

Zhang, Chen, Lum, Kah Yean, Taki, Aya C., Gasser, Robin B., Byrne, Joseph J., Wang, Tao, Blaskovich, Mark A.T., Register, Emery T., Montaner, Luis J., Tietjen, Ian and Davis, Rohan A. (2021). Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold. Phytochemistry, 190 112887, 1-10. doi: 10.1016/j.phytochem.2021.112887

Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold

2021

Other Outputs

Antibacterial Agents

Cooper, Matthew and Blaskovich, Mark (2021). Antibacterial Agents. CN107027309.

Antibacterial Agents

2021

Journal Article

Serum complement activation by C4BP-IgM fusion protein can restore susceptibility to antibiotics in Neisseria gonorrhoeae

Bettoni, Serena, Maziarz, Karolina, Stone, M. Rhia L., Blaskovich, Mark A. T., Potempa, Jan, Bazzo, Maria Luiza, Unemo, Magnus, Ram, Sanjay and Blom, Anna M. (2021). Serum complement activation by C4BP-IgM fusion protein can restore susceptibility to antibiotics in Neisseria gonorrhoeae. Frontiers in Immunology, 12 726801, 1-15. doi: 10.3389/fimmu.2021.726801

Serum complement activation by C4BP-IgM fusion protein can restore susceptibility to antibiotics in Neisseria gonorrhoeae

2021

Journal Article

Mesoporous silica nanoparticles improve oral delivery of antitubercular bicyclic nitroimidazoles

Ang, Chee Wei, Tan, Lendl, Qu, Zhi, West, Nicholas P., Cooper, Matthew A., Popat, Amirali and Blaskovich, Mark A.T. (2021). Mesoporous silica nanoparticles improve oral delivery of antitubercular bicyclic nitroimidazoles. ACS Biomaterials Science and Engineering, 8 (10) acsbiomaterials.1c00807, 4196-4206. doi: 10.1021/acsbiomaterials.1c00807

Mesoporous silica nanoparticles improve oral delivery of antitubercular bicyclic nitroimidazoles

2021

Journal Article

Antibiotic alternatives special issue

Blaskovich, Mark A. T. (2021). Antibiotic alternatives special issue. ACS Infectious Diseases, 7 (8), 2025-2026. doi: 10.1021/acsinfecdis.1c00388

Antibiotic alternatives special issue

2021

Journal Article

Targeted protein degradation: the new frontier of antimicrobial discovery?

Powell, Matthew, Blaskovich, Mark A. T. and Hansford, Karl A. (2021). Targeted protein degradation: the new frontier of antimicrobial discovery?. ACS Infectious Diseases, 7 (8) acsinfecdis.1c00203, 2050-2067. doi: 10.1021/acsinfecdis.1c00203

Targeted protein degradation: the new frontier of antimicrobial discovery?

2021

Journal Article

Antimicrobial screening of a historical collection of over 140 000 small molecules

Semenov, Victor V., Raihstat, Mikhail M., Konyushkin, Leonid D., Semenov, Roman V., Blaskovich, Mark A. T., Zuegg, Johannes, Elliott, Alysha G., Hansford, Karl A. and Cooper, Matthew A. (2021). Antimicrobial screening of a historical collection of over 140 000 small molecules. Mendeleev Communications, 31 (4), 484-487. doi: 10.1016/j.mencom.2021.07.015

Antimicrobial screening of a historical collection of over 140 000 small molecules

2021

Journal Article

The antimicrobial resistance crisis: an inadvertent, unfortunate but nevertheless informative experiment in evolutionary biology

Michael, Carolyn A., Gillings, Michael R., Blaskovich, Mark A. T. and Franks, Ashley E. (2021). The antimicrobial resistance crisis: an inadvertent, unfortunate but nevertheless informative experiment in evolutionary biology. Frontiers in Ecology and Evolution, 9 692674. doi: 10.3389/fevo.2021.692674

The antimicrobial resistance crisis: an inadvertent, unfortunate but nevertheless informative experiment in evolutionary biology

2021

Journal Article

Chemical synthesis of TFF3 reveals novel mechanistic insights and a gut-stable metabolite

Braga Emidio, Nayara, Meli, Rajeshwari, Tran, Hue N. T., Baik, Hayeon, Morisset-Lopez, Séverine, Elliott, Alysha G., Blaskovich, Mark A. T., Spiller, Sabrina, Beck-Sickinger, Annette G., Schroeder, Christina I. and Muttenthaler, Markus (2021). Chemical synthesis of TFF3 reveals novel mechanistic insights and a gut-stable metabolite. Journal of Medicinal Chemistry, 64 (13) acs.jmedchem.1c00767, 9484-9495. doi: 10.1021/acs.jmedchem.1c00767

Chemical synthesis of TFF3 reveals novel mechanistic insights and a gut-stable metabolite

2021

Journal Article

There is no market for new antibiotics: this allows an open approach to research and development

Klug, Dana M., Idiris, Fahima I. M., Blaskovich, Mark A. T., von Delft, Frank, Dowson, Christopher G., Kirchhelle, Claas, Roberts, Adam P., Singer, Andrew C. and Todd, Matthew H. (2021). There is no market for new antibiotics: this allows an open approach to research and development. Wellcome Open Research, 6 146, 146. doi: 10.12688/wellcomeopenres.16847.1

There is no market for new antibiotics: this allows an open approach to research and development

2021

Journal Article

Virtual Issue: Anti-infective Discovery Down Under

Blaskovich, Mark (2021). Virtual Issue: Anti-infective Discovery Down Under. ACS Infectious Diseases, 7 (6), 1555-1557. doi: 10.1021/acsinfecdis.1c00196

Virtual Issue: Anti-infective Discovery Down Under

Current funding

  • 2025 - 2026
    A Facility for Accelerated Microbial Phenotyping in Southeast Queensland
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2024 - 2027
    Camelid antibodies to combat antimicrobial resistance
    Australia-India Strategic Research Fund
    Open grant
  • 2024 - 2026
    Investigations into the antibacterial mechanism of action of cannabidiol
    ARC Discovery Projects
    Open grant
  • 2024 - 2026
    Seeing the Unseen: Imaging Bacterial Infections
    NHMRC IDEAS Grants
    Open grant
  • 2023 - 2025
    A novel, portable, low-cost oxygen therapy to improve wound healing using photosynthetic light (2023 RBWH Translational Research Grant administered by RBWH)
    Metro North Hospital and Health Service
    Open grant
  • 2023 - 2028
    ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance (ARC CEA-StAR)
    ARC Industrial Transformation Training Centres
    Open grant
  • 2021 - 2025
    OctapeptinX Potentiators to treat XDR Gram-negative infections
    NHMRC Development Grant
    Open grant
  • 2020 - 2025
    Rapid detection of drug resistant tuberculosis using real-time sequencing (MRFF Tackling Antimicrobial Resistance and Drug Resistant TB grant led by Uni Melbourne)
    University of Melbourne
    Open grant

Past funding

  • 2023
    CSIRO Library Screening
    CSIRO
    Open grant
  • 2023 - 2025
    Enhancing Australian biodiscovery molecule generation, storage and access (ARC LIEF administered by Griffith University)
    Griffith University
    Open grant
  • 2022
    CSIRO Library Screening
    CSIRO
    Open grant
  • 2022 - 2024
    Molecular Accumulation in single cells via microfluidics and omics (BBSRC grant administered by University of Exeter)
    University of Exeter
    Open grant
  • 2021 - 2022
    A study of the antimicrobial efficacy of Calix bioactive materials
    Calix Limited
    Open grant
  • 2021 - 2023
    Advanced Nuclear Magnetic Resonance Technologies for Southeast Queensland
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2021 - 2023
    Antibiotic Conjugates: Joining Together to Fight Antimicrobial Resistance
    NHMRC IDEAS Grants
    Open grant
  • 2021 - 2024
    Predictive Models to Design and Develop New Antibiotics Derived from the Community for Open Antimicrobial Drug Discovery
    NHMRC IDEAS Grants
    Open grant
  • 2020
    Sequencing Analysis of CBD-Induced Resistance S. saprophyticus
    Botanix Pharmaceuticals Ltd
    Open grant
  • 2020
    Cannabodiol analog synthesis and characterisation
    Botanix Pharmaceuticals Ltd
    Open grant
  • 2020 - 2023
    Breaking antibiotic resistance in high priority Gram-negative sepsis pathogens
    NHMRC Development Grant
    Open grant
  • 2019 - 2020
    Continued Investigations into the Antimicrobial Activity of Cannabidiol
    Innovation Connections
    Open grant
  • 2019 - 2020
    Antibacterial Potentiation Screening 1. Master Research Services Agreement - Statement of Work no.3
    Global Antibiotic Research & Development Partnership Foundation
    Open grant
  • 2019
    Antibacterial Potentiation Screening 1. Master Research Services Agreement - Statement of Work no.2
    Global Antibiotic Research & Development Partnership Foundation
    Open grant
  • 2019
    Antibacterial Screening 1. Master Research Services Agreement - Statement of Work no.1
    Global Antibiotic Research & Development Partnership Foundation
    Open grant
  • 2019
    In vivo imaging system for tracking inflammation, infection, cancer, pain and bioactive molecules
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2019
    Investigations into the Antimicrobial Activity of Cannabidiol
    Innovation Connections
    Open grant
  • 2018 - 2021
    Lipopeptide antibiotics for XDR Gram-negative infections
    NHMRC Development Grant
    Open grant
  • 2018 - 2021
    Rapid Diagnosis of Microbial Infections Without Culture
    Defence Materials Technology Centre
    Open grant
  • 2017 - 2018
    Natureceuticals from post-production wine extracts
    Innovation Connections
    Open grant
  • 2017 - 2018
    Antibody-antibiotic conjugates to treat drug-resistant Gram-ve infections
    Global Connections Fund
    Open grant
  • 2017 - 2020
    Rapid diagnosis of pathogenic infections
    Queensland Government Advance Queensland Innovation Partnerships
    Open grant
  • 2017
    Natureceuticals from post-production wine extracts
    Innovation Connections
    Open grant
  • 2017 - 2023
    Open Access Award
    The Wellcome Trust
    Open grant
  • 2016
    Antibody-antibiotic conjugates to treat drug-resistant bacteria
    Global Connections Fund
    Open grant
  • 2016 - 2017
    Community for Open Antimicrobial Drug Discovery (CO-ADD) Indonesian Engagement Program
    Commonwealth Department of Foreign Affairs & Trade
    Open grant
  • 2016 - 2019
    Novel membrane-targeted antibiotics against drug-resistant Gram-positive bacterial infections
    NHMRC Development Grant
    Open grant
  • 2015 - 2019
    Community for Open Antimicrobial Drug Discovery (CO-ADD)
    The Wellcome Trust
    Open grant
  • 2014 - 2015
    Effect of Sputum Surrogate on Amikacin activity with and without fosfomycin
    UniQuest Pty Ltd
    Open grant
  • 2014 - 2015
    Antimicrobial activity of MTC896 against common skin bacteria
    UniQuest Pty Ltd
    Open grant
  • 2014
    Continuous-Flow Hydrogenation Reactor (H-Cube Pro)
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014
    Enrichment, detection and identification of bacteria in blood and urine.
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant

Availability

Professor Mark Blaskovich is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Functionalised antibiotics for diagnostics and therapeutics

    The increasing incidence of infections caused by drug resistant bacteria and fungi poses a significant and increasing threat to global human health, with predicted annual mortality of 10 million people by 2050. It is imperative to advance new technologies capable of rapidly and accurately diagnosing infections to enable timely and appropriate therapy. We must develop new antibiotics with efficacy against multidrug-resistant bacteria and fungi, and new methods to rapidy diagnose infections. To enable this we require fundamental studies that probe the chemical biology of antibiotic action and investigate microbial growth, metabolism and resistance.

    This research program is designed to achieve these goals, based on the chemical functionalisation of antibiotics with a readily derivatised handle. The resulting set of versatile intermediates is then modified to create 1) fluorescent probes that can catalyse basic research and lead to new assays, 2) clinical imaging agents to visualise microbial infections, and 3) novel hybrid therapeutics. The project requires talented synthetic organic chemists with an interest in multidisciplinary research.

Supervision history

Current supervision

  • Doctor Philosophy

    Conotoxins - advanced probes for studying pain pathways

    Principal Advisor

    Other advisors: Professor Joanne Blanchfield

  • Doctor Philosophy

    Disrupting Bacterial Proteostasis through ClpP Activation

    Principal Advisor

    Other advisors: Dr Anthony Verderosa

  • Doctor Philosophy

    Investigations of novel antimicrobial agents and formulations to treat topical agricultural infections.

    Principal Advisor

    Other advisors: Dr Conny Turni

  • Doctor Philosophy

    Clicking Conjugates into Place for the Fight Against Antibiotic Resistance

    Principal Advisor

    Other advisors: Professor Joanne Blanchfield, Dr Anthony Verderosa

  • Doctor Philosophy

    Bio-evaluation of Human Tyrosinase Inhibitors as Potential Anti-melanoma Agents and Novel Treatment for Parkinson's Disease

    Principal Advisor

    Other advisors: Dr Zyta M Ziora

  • Doctor Philosophy

    Novel antibiotics containing tyrosinase inhibitors

    Principal Advisor

    Other advisors: Dr Zyta M Ziora

  • Doctor Philosophy

    Translating the Targeted Protein Degradation therapeutic approach into the context of antibacterial drug discovery: Investigating bacterial protease-engaging antibacterial degrader constructs

    Principal Advisor

    Other advisors: Dr Anthony Verderosa

  • Doctor Philosophy

    Investigations of the interactions between fluorescent antibiotics and bacteria

    Principal Advisor

    Other advisors: Dr Sanjaya Kc, Dr Anthony Verderosa

  • Doctor Philosophy

    Antibiotic potentiators as an alternative therapeutic option for the treatment of extensively drug-resistant Gram-negative infections.

    Principal Advisor

    Other advisors: Dr Johannes Zuegg

  • Doctor Philosophy

    Selenium - The SuperElement against Superbugs

    Principal Advisor

    Other advisors: Professor Joanne Blanchfield

  • Doctor Philosophy

    Understanding Molecular Accumulation in antimicrobial resistant microbes

    Principal Advisor

  • Master Philosophy

    The antibacterial mechanism of action of cannabidiol

    Principal Advisor

    Other advisors: Dr Johannes Zuegg, Dr Tanuka Sen

  • Doctor Philosophy

    Understanding Molecular Accumulation in antimicrobial resistant microbes

    Principal Advisor

  • Doctor Philosophy

    Antibiotic Conjugates: Joining Together to Fight Antimicrobial Resistance

    Principal Advisor

    Other advisors: Professor Vito Ferro

  • Doctor Philosophy

    Antibiotic Conjugates: Joining Together to Fight Antimicrobial Resistance

    Principal Advisor

    Other advisors: Professor Vito Ferro, Dr Anthony Verderosa

  • Doctor Philosophy

    Sustainable antimicrobial coating materials for potential face mask application

    Associate Advisor

    Other advisors: Professor Alan Rowan, Dr Nasim Amiralian

  • Doctor Philosophy

    Mechanism of action of MgO

    Associate Advisor

    Other advisors: Dr Conny Turni, Professor Ian Henderson

  • Doctor Philosophy

    Targeting the Biogenesis of Resistance Enzymes to Combat Antimicrobial Resistance

    Associate Advisor

    Other advisors: Professor Ulrike Kappler, Professor Ian Henderson, Dr Anthony Verderosa

  • Doctor Philosophy

    Sustainable Antimicrobial Coating Materials for Potential Face Mask Applications

    Associate Advisor

    Other advisors: Professor Alan Rowan, Dr Nasim Amiralian

  • Doctor Philosophy

    Mechanism of action of MgO

    Associate Advisor

    Other advisors: Dr Conny Turni, Professor Ian Henderson

  • Doctor Philosophy

    Development of Metal Organic Frameworks for targeted oral drug delivery

    Associate Advisor

    Other advisors: Professor Amirali Popat

  • Doctor Philosophy

    Seeing the Unseen: Imaging Bacterial Infections

    Associate Advisor

    Other advisors: Professor Kristofer Thurecht, Dr Rhia Stone

  • Doctor Philosophy

    Development of Biobased Silver Nano-Particles for Application as Wastewater Disinfectant

    Associate Advisor

    Other advisors: Dr Zyta M Ziora

  • Doctor Philosophy

    Sustainable antimicrobial coating materials for potential face mask application

    Associate Advisor

    Other advisors: Professor Alan Rowan, Dr Nasim Amiralian

  • Doctor Philosophy

    Seeing the Unseen: Imaging Bacterial Infections

    Associate Advisor

    Other advisors: Professor Kristofer Thurecht, Dr Rhia Stone

  • Doctor Philosophy

    A global quantitative genetic network for Escherichia coli

    Associate Advisor

    Other advisors: Professor Ian Henderson

  • Doctor Philosophy

    Targeting bacterial biofilms in patients with gastrointestinal disorders

    Associate Advisor

    Other advisors: Associate Professor Markus Muttenthaler

  • Doctor Philosophy

    Development of computational models to discover new antibiotics against Gram-negative bacteria. (Note: online component of Onawole's application lists his Master's thesis title instead of this project)

    Associate Advisor

    Other advisors: Dr Johannes Zuegg

  • Doctor Philosophy

    A global quantitative genetic network for Escherichia coli

    Associate Advisor

    Other advisors: Professor Ian Henderson

  • Doctor Philosophy

    Synthesis and Physico-chemical characterization of waste derived carbon adsorbents for wastewater treatment

    Associate Advisor

    Other advisors: Dr Zyta M Ziora

  • Doctor Philosophy

    How does cannabidiol kill bacteria?

    Associate Advisor

    Other advisors: Dr Johannes Zuegg

  • Doctor Philosophy

    Mechanism of action of MgO

    Associate Advisor

    Other advisors: Dr Conny Turni, Dr Sean Bisset, Professor Ian Henderson

  • Doctor Philosophy

    Medicinal chemistry strategies to remove bacterial biofilms associated with gastrointestinal disorders

    Associate Advisor

    Other advisors: Associate Professor Markus Muttenthaler

  • Doctor Philosophy

    Development of Metal Organic Frameworks for targeted oral drug delivery

    Associate Advisor

    Other advisors: Dr Anjana Jayasree, Professor Amirali Popat

Completed supervision

Enquiries

Contact Professor Mark Blaskovich directly for media enquiries about:

  • acne
  • antibiotic resistance
  • antibiotics
  • antimicrobial resistance
  • antimicrobial resistance antibiotics
  • bacteria
  • bacterial detection
  • bacterial infection
  • bacterial resistance
  • drug design
  • drug development
  • drug discovery
  • E. coli
  • glycopeptide antibiotics
  • golden staph
  • gram negative bacteria
  • gram positive bacteria
  • microbiome
  • octapeptin
  • superbugs

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au